Overcoming tumor resistance to chemotherapy drugs has long been a challenge for oncology clinicians and researchers.
Oct 24 (Reuters) - A newer class of cancer drugs can delay disease progression or extend survival for breast cancer patients, multiple teams of researchers reported at a major European oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results